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Available online 2 November 2015AbstractBackground/objective: Tarsal tunnel syndrome is a relatively rare entrapment neuropathy with the lateral and medial plantar nerves entrapped
inside of the tarsal tunnel. When conservative treatment fails, standard open decompression of the nerve can be achieved by releasing the flexor
retinaculum of the foot through a several-centimetre-long skin incision made along the tarsal tunnel. By contrast, we made a 1-cm portal incision
at the proximal part of the medial ankle, and endoscopic tarsal tunnel release of the flexor retinaculum of the foot and part of the abductor
hallucis muscle was achieved using the Universal Subcutaneous Endoscope (USE) system.
Methods: Our procedure was performed under local anaesthesia without a pneumatic tourniquet on an outpatient basis. The USE system was
inserted into the tarsal tunnel at the proximal part of the medial ankle; the nerves, vessels, flexor retinaculum, tendons of the foot, and the
abductor hallucis muscle were then endoscopically identified. Decompression of the lateral and medial plantar nerves entrapped inside of the
tarsal tunnel was then achieved by releasing the flexor retinaculum of the foot and part of the abductor hallucis muscle with a push knife under
complete endoscopic observation.
Results: Results from eight feet of five patients were compiled and analyzed. All showed improved clinical signs compared with their pre-
operative condition.
Conclusion: Our less invasive endoscopic management for tarsal tunnel syndrome using the USE system produces sufficient results.
Copyright © 2016, Asia Pacific Knee, Arthroscopy and Sports Medicine Society. Published by Elsevier (Singapore) Pte Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Tarsal tunnel syndrome is a relatively rare entrapment
neuropathy. When the lateral and medial plantar nerves are
entrapped inside of the tarsal tunnel, pain, paraesthesia, and/or
sensory loss in the medial and/or the lateral branch area of the
plantar aspect occurs. In some cases weakness or atrophy of
the abductor hallucis muscle, and/or other foot intrinsic* Corresponding author. Okutsu Minimally Invasive Orthopaedic Clinic,
3rd floor, Daini-Sano Building, 5-10-24, Minami-Azabu, Minato-ku, Tokyo
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article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nmuscles also controlled by the tibial nerve occurs. Clinical
signs worsen at night and/or during the day due to overuse of
the foot. There is positive percussion test (Tinel-like sign) at
the tarsal tunnel. Electrophysiological examinations show
decreased conduction velocity at the tarsal tunnel.
When conservative treatment fails, surgery is considered.
The standard open procedure requires a several-centimetre-
long skin incision along the tarsal tunnel. The wide skin
incision and subsequent exploration enables the surgeon to
directly observe nerves, vessels, and identify possible entrap-
ment points. Healthy tissues, however, are coincidentally
damaged during this open procedure.e Society. Published by Elsevier (Singapore) Pte Ltd. This is an open access
c-nd/4.0/).
Figure 1. The Universal Subcutaneous Endoscope system and a push knife are
inserted into the tarsal tunnel. The photograph shows the correct operative
position of the foot. USE system ¼ Universal Subcutaneous Endoscope
system.
Figure 2. Endoscopic internal view of the flexor retinaculum of the foot.
Figure 3. Endoscopic view of the medial and lateral plantar nerve.
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treatment of tarsal tunnel syndrome, we applied an endoscopic
procedure using the Universal Subcutaneous Endoscope
(USE) system (Tact Medical Inc., Tokyo, Japan). The USE
system consists of a standard 30 4-mm oblique viewing
arthroscope and a tapered 6e8-mm diameter transparent
closed sheath (USE sheath). It has been developed and used in
subcutaneous surgical treatments such as carpal tunnel syn-
drome, cubital tunnel syndrome, shoulder impingement syn-
drome, and benign bone tumours since 1986.1e7
We compiled and analysed the clinical results of our
endoscopic surgeries to verify the efficacy of this less invasive
procedure for the treatment of tarsal tunnel syndrome.
Methods
We have retrospectively compiled, examined, and analysed
the results from all of our patients who underwent endoscopic
neurolysis using the USE system for tarsal tunnel syndrome
since 2004.
Diagnosis was performed using clinical signs, such as
tingling and touch sensation evaluated using 2g von Frey hair
at the tibial nerve distribution area and manual muscle testing
of the abductor hallucis muscle, Tinel-like sign at the tarsal
tunnel, and electrophysiological test results (decreased motor
nerve conduction velocity between the entrance and exit of the
tarsal tunnel). Surgery was performed on patients who failed
to show any signs of recovery following > 2 months of con-
servative treatment, e.g., the taking of nonsteroidal anti-
inflammatory drugs and/or steroid injections directly into the
tarsal tunnel. Indications for our endoscopic procedure also
include idiopathic, haemodialysis-related tarsal tunnel syn-
drome. Space occupying lesions such as lipoma, ganglion,
aneurysm, or anomalies do not serve as indications for our
endoscopic procedure.
Eight feet of five cases (3 men and 2 women) were included
in this study. One case had no apparent cause (2 feet) and four
were haemodialysis-related (6 feet). The mean age at the time
of operation (standard deviation; SD) was 62.4 (12.1) years
old (range, 44e75 years) and mean follow up period (SD) was
14.4 (10.9) months (range, 3.6e32 months).
Surgeries were performed under local anaesthesia (5 ml of
2% lidocaine containing epinephrine is applied to the skin
incision area and 10 ml of 1% lidocaine containing epineph-
rine is injected into the tarsal tunnel) on an out-patient basis. If
the patients complained of referred pain to the foot and/or if
blood returned into the syringe during administration of local
anaesthetic agent, we stopped the injection and changed the
injection area to avoid nerve and vessel injuries. A pneumatic
tourniquet is not used so that we can identify blood circulation
of the artery and vein during surgery thus avoiding vascular
injury. A 1-cm portal skin incision was made at the proximal
part of the flexor retinaculum of the foot. The USE system was
inserted into the tarsal tunnel through the portal (Figure 1).
Correct positioning of the foot is crucial when placing the tip
of the USE system because correct positioning of the foot
allows us to advance from the portal to the proximal part ofthe abductor hallucis muscle, i.e., the proximal part (entrance)
of the abductor canal. The flexor retinaculum of the foot
(Figure 2), nerves (Figure 3), and vessels were endoscopically
identified in order to avoid injury to nerves and vessels due to
Figure 4. Endoscopic view of releasing the flexor retinaculum of the foot using
a push knife.
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to the USE sheath through the portal, and the flexor retinac-
ulum of the foot and a part of the abductor hallucis muscle
were then released from proximal to distal (Figure 4). If a
patient complained of pain during surgery, we administered
sufficient local anaesthetic under complete endoscopic
observation. Endoscopic observation of the blood reperfusion
of the nerves served to verify sufficient decompression of the
nerve. We endoscopically confirmed that there was no arterial
bleeding; however, if there is bleeding, endoscopically hae-
mostasis can be done using a ligation technique from the
surface skin to the injured vessels, manual compression, and/
or a bipolar coagulator can also be used. A blunt obturator was
used to confirm complete release of the tarsal tunnel
(Figure 5). The skin incision was not sutured to allow for
blood drainage and patients were recommended to avoid
weight-bearing activity for 1 postoperative week.
Written informed consent was obtained from all partici-
pating patients in this treatment. This study was performed in
accordance with the World Medical Association Declaration
of Helsinki.Figure 5. Complete release confirmation of the tarsal tunnel using an obturator.Results
Preoperatively, all patients complained of tingling in the
affected foot, positive Tinel-like signs, and sensory distur-
bance. Abnormal motor nerve conduction velocity existed in
all feet and three feet showed muscle weakness (Table 1).
In foot five and foot six (same patient), the os tibiale
externum that had remained following childhood surgery was
excised via another small skin incision made after completion
of the endoscopic tarsal tunnel release procedure.
Postoperatively, all eight feet showed improved rating
scores (Table 2).8 Mean recovery times (SD) were 2.9 (3.1)
months (range, 0.1e8.2 months) for tingling sensation; 2.9
(2.8) months (range, 0.1e8.2 months) for sensory disturbance;
and 2.9 (4.6) months (range, 0.1e8.2 months) for muscle
weakness. Motor nerve conduction velocity improved in 11.8
(3.7) months (range, 8.1e16.4 months) in 80% of results
detectable feet.
Foot number one showed manual muscle testing level 2
muscle weakness of the abductor hallucis muscle at 13 post-
operative months. Foot number four and six exhibited tingling
until 10 postoperative weeks. Foot number six also showed
hypaesthesia and hypalgesia at 9.6 postoperative months.
Postoperative complications were one haematoma forma-
tion and two feet with postoperative tingling in the calcaneal
branch area; however, no further surgical treatments were
required. Haematoma formation was spontaneously absorbed
and postoperative tingling was treated with Vitamin B12 taken
orally. There was no recurrence in this series during follow-up
periods.
Discussion
The purpose of surgical treatment of tarsal tunnel syndrome
is decompression of the tibial nerve inside of the tarsal tunnel.
Although some satisfactory postoperative results have been
reported, Pfeiffer and Cracchiolo9 reported less satisfactory
postoperative results following standard exploration and
decompression with only 44% having “good” or “excellent”
results. They reported the existence of varicosities, tighter
retinaculum, and rheumatoid arthritis in the “poor”
postoperative-result patients. Barker et al10 reported 44 feet
undergoing revision tarsal tunnel surgery that needed neu-
rolysis, resection of intertunnel septum, neuroma resection (as
indicated), and listed poor prognosis risk factors as coexisting
lumbosacral disc disease and/or neuropathy. Every patient in
our series, except patients with feet five and six, had possible
histories of peripheral nerve disease as entrapment neuropa-
thies of the upper-extremities. Patients of foot one, four, seven,
and eight had been receiving haemodialysis for > 20 years and
had previously undergone surgery for bilateral carpal tunnel
syndrome. In foot six patient we had to insert the USE sheath
while simultaneously cutting the flexor retinaculum from
proximal with a push knife because of “the tight tarsal tunnel”
or “tight retinaculum” described by Pfeiffer and Cracchiolo.9
These clinical backgrounds may have affected postoperative
recovery in these cases; however, clinical and
Table 1
Profiles of the patients.
Foot no. Age/sex/laterality Medical history Duration of
symptoms (wk)
Abductor hallucis
muscle weakness
Preoperative motor nerve
conduction velocity (m/s)
Previous treatment
1 70/F/L HD 27 y
DSA (CS/LS)
Lt. Baker's cyst
Herpes zoster;
Bil. CTS
192 þ 17.6 Steroid injection
2a 62/M/L HD 2 y
Cervical spondylosis
DM
Bil. CTS
12 e 13
3a 62/M/R HD 2 y
Cervical spondylosis
DM
Bil. CTS
19 e 7.6
4 62/M/L HD 22 y
Lumber disc herniation
Bil. CTS
40 e 28
5a 44/M/R Os tibiale externum 208 þ 38 Steroid injection
6a 45/M/L Os tibiale externum 208 þ 49
7a 75/F/R HD 41 y
DSA (CS/LS)
Parkinsonism
Bil. CTS
104 e 31 Steroid injection
8a 75/F/L HD 41 y
DSA (CS/LS)
Parkinsonism
Bil. CTS
104 e 41
CS ¼ cervical spine; CTS ¼ carpal tunnel syndrome; DM ¼ diabetes mellitus; DSA ¼ destructive spondyloarthropathy; F ¼ female; HD ¼ haemodialysis;
L ¼ left; LS ¼ lumbar spine; M ¼ male; R ¼ right.
a Same patient: feet two and three; feet five and six; feet seven and eight.
Table 2
Pre- and postoperative clinical symptoms.
Foot no. Preop. rating scorea Postop.
Pain Tingling Tinel-like sign Sensory disturbance Muscle weakness MCV (m/s) Rating scorea
1 0  þ þ  þ (d) 4
2 2      32 10
3 2      43 10
4 2  þ    42 8
5 0      37 10
6 0  þ  þ  51 6
7 2      (d) 10
8 2      (d) 10
MCV ¼ motor nerve conduction velocity; Postop. ¼ postoperative; Preop. ¼ preoperative.
a Rating score according to Takakura et al8 (1991).
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improved perineural environment following our procedure.
Other authors have previously reported endoscopic pro-
cedures for tarsal tunnel syndrome. Krishnan et al11 reported
an endoscopically assisted procedure that used a retractor to
create observation space in the tarsal tunnel, following
observation, and release of the tarsal tunnel from a several-
centimetre-wide skin incision under direct vision. They re-
ported five “excellent” and three “good” postoperative resultsin eight feet. Day and Naple12 reported a two-portal procedure
using a slotted cannula with an 89% success rate. All of these
procedures release from the flexor retinaculum to a part of the
abductor canal as Franson13 stressed the importance of
releasing the flexor retinaculum and the nerve distally, through
the abductor canal. However, there are some significant dif-
ferences between these procedures and ours. Our characteristic
closed transparent sheath, used without a pneumatic tourni-
quet, enables us to observe the nerve and vessels without blood
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endoscopic portal, the 10-cm USE sheath allows us to
confirm sufficient length of tibial nerve decompression from
the proximal part of the flexor retinaculum to the abductor
hallucis muscle. The USE system allows us to observe restored
intranerve blood circulation during the operation and verify
complete decompression of the nerve. Because insufficient
release and perineural scar formation lead to poor post-
operative results, it is important to have a clear field of vision,
avoiding interference bleeding during the endoscopic proce-
dure and to prevent postoperative perineural adhesion after the
endoscopic procedure.
As a limitation of this procedure, ganglion and bony spur
formation cases (such as tarsal coalition), the most frequent
cause for tarsal tunnel syndrome,8,14,15 are not indicated for
our procedure because it does not achieve complete decom-
pression when they exist. Although some surgeons may fear
damaging nerves with insertion of the USE sheath, we have
shown that no nerve damage occurs during the average 3-
minute insertion of the USE sheath as proven in our carpal
tunnel syndrome surgeries.16 Our postoperative clinical re-
covery results from tarsal tunnel syndrome reveal the effec-
tiveness of this procedure.
Conclusion
Endoscopic treatment using the USE system is an appro-
priate less invasive procedure for the treatment of tarsal tunnel
syndrome. Decompression of the tibial nerve is achieved
without nerve and/or vessel damage during release of the
flexor retinaculum of the foot and a part of the abductor hal-
lucis muscle.
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